[lcus_masonry_article]<\/p>\n
This article discusses computational research findings. It is not medical advice.<\/em><\/p>\n Each of the four research packages includes at least one 11×17 landscape SVG chart, designed to be printed on tabloid paper and pinned to a wall, slid into a binder, or shared in a research setting. The charts use light backgrounds and dark text \u2014 no dark themes, fully print-friendly.<\/p>\n Research Reference Charts<\/strong> provide an overview of each project: compound rankings, mechanism coverage matrices, published evidence summaries, safety warnings, methodology notes, and data summaries \u2014 all on one page.<\/p>\n Formulation Charts<\/strong> (included for diabetes, Alzheimer’s, and Parkinson’s) present theoretical supplement formulations in a pharmacist-readable format. These include compound names, CAS numbers, dosing schedules, mechanism-of-action maps, drug interaction warnings, and QC specifications. The formulation charts are named GlucoElement (diabetes), NeuroGuard-A (Alzheimer’s), and NeuroGuard-P (Parkinson’s).<\/p>\n The formulation charts describe theoretical combinations based on computational analysis. No formulation has been manufactured, tested, or approved. The charts are designed to be conversation starters with healthcare professionals, not instructions.<\/p>\n All charts include prominent safety warnings and the standard disclaimer.<\/p>\nDesigned for Print<\/h2>\n
Two Types of Charts<\/h2>\n
Important: These Are Theoretical<\/h2>\n